{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:58:02Z","timestamp":1781323082677,"version":"3.54.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6015-25","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:09:40Z","timestamp":1781129380000},"source":"Crossref","is-referenced-by-count":0,"title":["Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a <i>CFH<\/i> variant: A case report"],"prefix":"10.2169","author":[{"given":"Mako","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Ubukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kameoka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Joh","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Campistol JM, Arias M, Ariceta G, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 35: 421-447, 2015.","DOI":"10.1016\/j.nefro.2015.07.005"},{"key":"2","unstructured":"2. Available from: https:\/\/jsn.or.jp\/academicinfo\/report\/aHUS_GL2023.pdf"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Yoshida Y, Miyata T, Matsumoto M, et al. Diagnosis and gene mutations of atypical HUS in Japan. PLOS One 10: e0124655, 2015.","DOI":"10.1371\/journal.pone.0124655"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kato N, Tatematsu Y, Maruyama S. Pathophysiology and clinical aspects of aHUS. Nihon Kessen Shikethu Gakkaishi (Jpn J Thromb Hemostasis) 31: 45-54, 2020 (in Japanese).","DOI":"10.2491\/jjsth.31.45"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Satoh K, Okuyama M, Irie Y, et al. Continuous plasma exchange with dialysis for thrombotic microangiopathy in intensive care unit: retrospective observational study. Ther Apher Dial 25: 377-383, 2021.","DOI":"10.1111\/1744-9987.13654"},{"key":"6","unstructured":"6. Akiko M, Akira S. Renal pathology of thromobotic microangiopathy. Jpn J Nephro 56: 1031-1042, 2014 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Selcuk Y, Ipek IG, Nur C, et al. Renal biopsy prognostic findings in children with atypical hemolytic uremic syndrome. Pediatr Dev Pathol 23: 362-371, 2020.","DOI":"10.1177\/1093526620925947"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Basak R, Wang X, Keane C, et al. Atypical presentation of atypical uraemic syndrome. BMJ Case Report 2018.","DOI":"10.1136\/bcr-2017-222560"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. V\u00e9ronique FB, Fadi F, Arnaud G, et al. Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults. Clin J Am Soc Nephrol 8: 554-562, 2013.","DOI":"10.2215\/CJN.04760512"},{"key":"10","unstructured":"10. Rondeau E, Scully M, Ariceta G, et al. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome na\u00efve to complement inhibitor treatment. Kidney Int 97: 1287-1296, 2020."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Eng J Med 361: 1676-1687, 2009.","DOI":"10.1056\/NEJMra0902814"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Franz S, Gianluigi A, Gema A, et al. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney Int 94: 408-418, 2018.","DOI":"10.1016\/j.kint.2018.02.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hossain MA, Cheema A, Kalathil S, et al. Atypical hemolytic uremic syndrome: laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations. Saudi J Kidney Dis Transpl 29: 276-283, 2018.","DOI":"10.4103\/1319-2442.229287"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Magdalena R, Dorothea OH, Reinhard W. Seminars in Thrombosis & Hemostasis. 40: 413-415, 2014.","DOI":"10.1055\/s-0034-1376521"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tsai HM. Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med 126: 200-209, 2013.","DOI":"10.1016\/j.amjmed.2012.09.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Miguel EN, Lucas dMS, Halita VGV, et al. Histopathological features of thrombotic microangiopathies in renal biopsies. J Nephropathol 8: 2019.","DOI":"10.15171\/jnp.2019.27"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Valoti E, Alberti M, Iatropoulos P, et al. Rare functional variants in complement genes and anti-FH autoantibodies-associated aHUS. Front Immunol 10: 853, 2019.","DOI":"10.3389\/fimmu.2019.00853"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rodriguez E, Rallapalli PM, Osborne AJ, Perkins SJ. New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3. Biosci Resp 34: e00146, 2014.","DOI":"10.1042\/BSR20140117"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Geerlings MJ, Volokhina EB, de Jong EK, et al. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration. Clin Genet 94: 330, 2018.","DOI":"10.1111\/cge.13392"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6015-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:48:49Z","timestamp":1781322529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6015-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6015-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6015-25"}}